DiaTech Oncology Receives New York State Clinical Laboratory Permit

News   Jun 26, 2013

 
DiaTech Oncology Receives New York State Clinical Laboratory Permit
 
 
 

RELATED ARTICLES

Investigational Drug for Melanoma Shows Promise in Early-Stage Study

News

An investigational compound designed to block a hyperactive cell growth signal in advanced melanoma and other cancers has shown some promise in an early-stage clinical trial researchers have reported.

READ MORE

‘Mini Tumors’ from Patient Samples Could Help Personalize Cancer Drug Treatment

News

Testing cancer drugs on miniature replicas of a patient’s tumour could help doctors tell in advance which treatments will work, a major new study reports.

READ MORE

Discovery of Exomeres Could Help Reveal How Cancer Cells Spread

News

A new cellular messenger discovered by Weill Cornell Medicine scientists may help reveal how cancer cells co-opt the body's intercellular delivery service to spread to new locations in the body.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE